Cargando…

Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure

PURPOSE: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a serious medical condition with a high short-term mortality rate, making accurate prognostic assessment essential for informed clinical decision-making. In this study, we aimed to develop a simple and effective prognost...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Yang, Kai, Wang, Qin, Jin, Lei, Wang, Ling-Mei, Fan, Xing-Yu, Wang, Xiu, Zhou, Qiang, Xu, Yuan-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162102/
https://www.ncbi.nlm.nih.gov/pubmed/37152403
http://dx.doi.org/10.2147/IDR.S402585
_version_ 1785037630872748032
author Zhang, Hao
Yang, Kai
Wang, Qin
Jin, Lei
Wang, Ling-Mei
Fan, Xing-Yu
Wang, Xiu
Zhou, Qiang
Xu, Yuan-Hong
author_facet Zhang, Hao
Yang, Kai
Wang, Qin
Jin, Lei
Wang, Ling-Mei
Fan, Xing-Yu
Wang, Xiu
Zhou, Qiang
Xu, Yuan-Hong
author_sort Zhang, Hao
collection PubMed
description PURPOSE: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a serious medical condition with a high short-term mortality rate, making accurate prognostic assessment essential for informed clinical decision-making. In this study, we aimed to develop a simple and effective prognostic model for predicting short-term mortality in patients with HBV-ACLF. PATIENTS AND METHODS: To achieve our objective, we enrolled both a cross-sectional cohort (n = 291) and a retrospective cohort (n = 185) in this study. We collected laboratory and clinical data from these cohorts and performed univariate and multivariate logistic regression analyses to identify independent predictors of short-term mortality. Subsequently, we developed a novel prognostic score for HBV-ACLF, which was validated and assessed using receiver operating characteristic (ROC) curve analysis to determine its performance. RESULTS: Our analysis revealed that the admission prealbumin (PAB) level was a robust independent predictor of 30-day mortality, with an area under the receiver operating characteristic (AUROC) of 0.760. Moreover, we developed the HIAPP score, a prognostic-score model based on PAB. The HIAPP score was significantly lower in survivors compared to non-survivors (−2.80±0.21 vs 0.97±0.41, P < 0.001). The HIAPP score’s AUROC value was 0.899, which was found to be superior to the MELD score (AUROC = 0.795) and the CLIF-C ACLF score (AUC =0.781) and comparable to the COSSH-ACLF II score (AUC =0.825) for predicting 30-day mortality. These findings were also validated in a separate cohort, further supporting the utility of the HIAPP score as a prognostic tool for HBV-ACLF patients. CONCLUSION: Our study identifies the admission PAB level as a simple and valuable predictive index for 30-day mortality in HBV-ACLF patients. Furthermore, the HIAPP score, which incorporates PAB, PLT, INR, HE, and age, is an easy-to-use and pragmatic prognostic score in predicting short-term mortality.
format Online
Article
Text
id pubmed-10162102
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-101621022023-05-06 Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure Zhang, Hao Yang, Kai Wang, Qin Jin, Lei Wang, Ling-Mei Fan, Xing-Yu Wang, Xiu Zhou, Qiang Xu, Yuan-Hong Infect Drug Resist Original Research PURPOSE: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a serious medical condition with a high short-term mortality rate, making accurate prognostic assessment essential for informed clinical decision-making. In this study, we aimed to develop a simple and effective prognostic model for predicting short-term mortality in patients with HBV-ACLF. PATIENTS AND METHODS: To achieve our objective, we enrolled both a cross-sectional cohort (n = 291) and a retrospective cohort (n = 185) in this study. We collected laboratory and clinical data from these cohorts and performed univariate and multivariate logistic regression analyses to identify independent predictors of short-term mortality. Subsequently, we developed a novel prognostic score for HBV-ACLF, which was validated and assessed using receiver operating characteristic (ROC) curve analysis to determine its performance. RESULTS: Our analysis revealed that the admission prealbumin (PAB) level was a robust independent predictor of 30-day mortality, with an area under the receiver operating characteristic (AUROC) of 0.760. Moreover, we developed the HIAPP score, a prognostic-score model based on PAB. The HIAPP score was significantly lower in survivors compared to non-survivors (−2.80±0.21 vs 0.97±0.41, P < 0.001). The HIAPP score’s AUROC value was 0.899, which was found to be superior to the MELD score (AUROC = 0.795) and the CLIF-C ACLF score (AUC =0.781) and comparable to the COSSH-ACLF II score (AUC =0.825) for predicting 30-day mortality. These findings were also validated in a separate cohort, further supporting the utility of the HIAPP score as a prognostic tool for HBV-ACLF patients. CONCLUSION: Our study identifies the admission PAB level as a simple and valuable predictive index for 30-day mortality in HBV-ACLF patients. Furthermore, the HIAPP score, which incorporates PAB, PLT, INR, HE, and age, is an easy-to-use and pragmatic prognostic score in predicting short-term mortality. Dove 2023-05-01 /pmc/articles/PMC10162102/ /pubmed/37152403 http://dx.doi.org/10.2147/IDR.S402585 Text en © 2023 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Hao
Yang, Kai
Wang, Qin
Jin, Lei
Wang, Ling-Mei
Fan, Xing-Yu
Wang, Xiu
Zhou, Qiang
Xu, Yuan-Hong
Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
title Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
title_full Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
title_fullStr Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
title_full_unstemmed Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
title_short Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
title_sort prealbumin as a predictor of short-term prognosis in patients with hbv-related acute-on-chronic liver failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162102/
https://www.ncbi.nlm.nih.gov/pubmed/37152403
http://dx.doi.org/10.2147/IDR.S402585
work_keys_str_mv AT zhanghao prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure
AT yangkai prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure
AT wangqin prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure
AT jinlei prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure
AT wanglingmei prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure
AT fanxingyu prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure
AT wangxiu prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure
AT zhouqiang prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure
AT xuyuanhong prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure